These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31652100)

  • 41. Evaluation of laboratory disturbance risk when adding low-dose cotrimoxazole for PJP prophylaxis to regimens of high-grade glioma patients taking RAAS inhibitors.
    Coppens R; Yang J; Ghosh S; Gill J; Chambers C; Easaw JC
    J Oncol Pharm Pract; 2019 Sep; 25(6):1366-1373. PubMed ID: 30124122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Short-term Withdrawal of Levothyroxine, Induced Increase of Thyroid-stimulating Hormone and an Increase Ratio of Triiodothyronine to Thyroxine.
    Carlwe M; Schaffer T; Sjöberg S
    Eur Endocrinol; 2013 Mar; 9(1):37-39. PubMed ID: 30349609
    [No Abstract]   [Full Text] [Related]  

  • 43. Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves' disease.
    Uy HL; Reasner CA; Samuels MH
    Am J Med; 1995 Aug; 99(2):173-9. PubMed ID: 7625422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glucose-induced paradoxical hyperkalemia in patients with suppression of the renin-aldosterone system: prevention by sodium depletion.
    Radó JP
    J Endocrinol Invest; 1979; 2(4):401-6. PubMed ID: 395185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rhabdomyolysis after withdrawal of thyroid hormone in a patient with papillary thyroid cancer.
    Espiritu RP; Stan MN
    Endocr Pract; 2008 Nov; 14(8):1023-6. PubMed ID: 19095604
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma.
    Golger A; Fridman TR; Eski S; Witterick IJ; Freeman JL; Walfish PG
    J Endocrinol Invest; 2003 Oct; 26(10):1023-31. PubMed ID: 14759077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolomic profile of patients on levothyroxine treatment for hypothyroidism.
    Benabdelkamel H; Jaber MA; Dahabiyeh LA; Masood A; Almalki RH; Musambil M; Abdel Rahman AM; Alfadda AA
    Eur Thyroid J; 2023 Jul; 12(4):. PubMed ID: 37343156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Erythrocyte sodium/potassium adenosine triphosphatase in thyroid disease and nonthyroidal illness.
    Dasmahapatra A; Cohen MP; Grossman SD; Lasker N
    J Clin Endocrinol Metab; 1985 Jul; 61(1):110-5. PubMed ID: 2987290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.
    Haugen BR; Pacini F; Reiners C; Schlumberger M; Ladenson PW; Sherman SI; Cooper DS; Graham KE; Braverman LE; Skarulis MC; Davies TF; DeGroot LJ; Mazzaferri EL; Daniels GH; Ross DS; Luster M; Samuels MH; Becker DV; Maxon HR; Cavalieri RR; Spencer CA; McEllin K; Weintraub BD; Ridgway EC
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3877-85. PubMed ID: 10566623
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduction of erythrocyte (Na(+)-K+) ATPase activities in non-insulin-dependent diabetic patients with hyperkalemia.
    Mimura M; Makino H; Kanatsuka A; Yoshida S
    Metabolism; 1992 Apr; 41(4):426-30. PubMed ID: 1313528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of thyroid status on thyroid autoimmunity expression in euthyroid and hypothyroid patients with Hashimoto's thyroiditis.
    Rieu M; Richard A; Rosilio M; Laplanche S; Ropion V; Fombeur JP; Berrod JL
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):529-35. PubMed ID: 8187321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between thyroid function and lipid profiles, apolipoproteins, and high-density lipoprotein function.
    Jung KY; Ahn HY; Han SK; Park YJ; Cho BY; Moon MK
    J Clin Lipidol; 2017; 11(6):1347-1353. PubMed ID: 28958565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of the incidence and influencing factors of hyponatremia before
    Cao JJ; Yun CH; Xiao J; Liu Y; Wei W; Zhang W
    World J Clin Cases; 2021 Dec; 9(36):11173-11182. PubMed ID: 35071548
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS).
    Chang SC; Thibodeaux JR; Eastvold ML; Ehresman DJ; Bjork JA; Froehlich JW; Lau C; Singh RJ; Wallace KB; Butenhoff JL
    Toxicology; 2008 Jan; 243(3):330-9. PubMed ID: 18063289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intolerance.
    Jojima T; Shinzawa T; Ohira E; Sakurai S; Tomaru T; Iijima T; Kogai T; Usui I; Aso Y
    Endocr J; 2022 Aug; 69(8):941-945. PubMed ID: 35249899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The renin-angiotensin system in hypothyroidism of short duration.
    Elias AN; Kyaw T; Valenta LJ; Meshkinpour H
    Horm Metab Res; 1986 May; 18(5):349-51. PubMed ID: 3522392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum microRNA profiles in athyroid patients on and off levothyroxine therapy.
    Massolt ET; Chaker L; Visser TJ; Gillis AJM; Dorssers LCJ; Beukhof CM; Kam BLR; Franssen GJ; Brigante G; van Ginhoven TM; Visser WE; Looijenga LHJ; Peeters RP
    PLoS One; 2018; 13(4):e0194259. PubMed ID: 29649216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum thyroxine and thyroid-stimulating hormone concentration in hyperthyroid cats that develop azotaemia after radioiodine therapy.
    Peterson ME; Nichols R; Rishniw M
    J Small Anim Pract; 2017 Sep; 58(9):519-530. PubMed ID: 28661007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors related to clinical hypothyroid severity in thyroid cancer patients after thyroid hormone withdrawal.
    Huang SC; Wu VC; Lin SY; Sheu WH; Song YM; Lin YH; Wu CC; Chang WD
    Thyroid; 2009 Jan; 19(1):13-20. PubMed ID: 19072673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Children with differentiated thyroid cancer achieve adequate hyperthyrotropinemia within 14 days of levothyroxine withdrawal.
    Kuijt WJ; Huang SA
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6123-5. PubMed ID: 16091480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.